Prof Andrew Scott
Honorary (Professorial Fellow)
Department of Medicine
923 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Health technology assessment in nuclear medicine: Challenges and opportunities in Europe
DOI: 10.1016/j.eanmj.2026.1002152026
Journal article
Estimating total and diagnosed global cancer incidence and stage distribution from 1990 to 2050: a simulation-based analysis of 17 cancers
DOI: 10.1016/S1470-2045(26)00060-42026
Journal article
Estimating global cancer survival and mortality from 1990 to 2050: a simulation-based analysis of 17 cancers
DOI: 10.1016/S1470-2045(26)00061-62026
Journal article
Clinical outcomes and quality of life in glioblastoma patients treated with MR-guided adaptive radiotherapy using a 1.5 T MR-Linac in an Australian setting
DOI: 10.1016/j.ctro.2026.1011322026
Journal article
Estimating the impact of scaling up workforce personnel on global cancer mortality from 2030 to 2050: a simulation-based analysis of 17 cancers and 18 personnel types
DOI: 10.1016/S1470-2045(26)00062-82026
Research grants (ARC, NHMRC, MRFF)
Characterising the Plasma Proteome of Polymyalgia Rheumatica
2025
Research grants (ARC, NHMRC, MRFF)
Application of Molecular Imaging Biomarkers in Large Vessel Vasculitis and Polymyalgia Rheumatica
RECENT SCHOLARLY WORKS
2026
Journal article
World Health Assembly Resolution WHA78.13 "Strengthening Medical Imaging Capacity": Impact on Nuclear Medicine Globally.
DOI: 10.2967/jnumed.125.2716112026
Journal article
Theranostics and nuclear medicine practice in Asia-Pacific: an IAEA regional study
DOI: 10.1007/s00259-025-07678-12026
Journal article
Polymyalgia rheumatica patients presenting with atypical clinical features still exhibit characteristic 18F-FDG PET/CT findings
DOI: 10.1007/s00259-025-07665-62026
Journal article
Usefulness of CAIX-targeted PET in restaging clear cell renal cell carcinoma: detection of thyroid metastasis with [89Zr]Zr-girentuximab
DOI: 10.1016/j.eanmi.2026.1002662026
Journal article
Joint Australian Diabetes Society/Australian and New Zealand Society of Nuclear Medicine procedure guideline for FDG PET/CT imaging in patients with type 1 and type 2 diabetes
DOI: 10.1111/imj.70344